Overall Sales Growth
Overall sales grew 6.5% to $154.6 million, driven by MedTech business growth of 7.3%.
MedTech Segment Success
Interventional and Surgical, Orthopedics, and Wound Care each grew greater than 30%.
Robotic Surgery Program Launch
Two significant new programs are expected to contribute greater than $10 million in 2026, with further growth anticipated.
Positive Acquisition Performance
Recent acquisitions, UNIPEC and TPI, performed well ahead of expectations and were immediately accretive to earnings.
Reduction in Interest Expense
Interest expense was down significantly due to deleveraging of the balance sheet.
Contract Expansion Discussions
Discussions are underway to extend and expand a contract with the largest customer, including planning for significantly increased volumes.